A government-sponsored study published recently in The Open Neurology Journal concludes that cannabis provides relief to some chronic pain sufferers and that more clinical trials are needed—directly challenging DEA classification of the drug under "Schedule I," that reserved for substances with no medical uses. The study, sponsored by the State of California and conducted at the University of California Center for Medicinal Cannabis Research, calls the Schedule I placement "not accurate" and "not tenable."
Recent comments
12 weeks 4 days ago
16 weeks 5 days ago
18 weeks 2 days ago
18 weeks 3 days ago
30 weeks 5 days ago
36 weeks 3 days ago
47 weeks 3 days ago
48 weeks 2 days ago
49 weeks 6 days ago
50 weeks 3 days ago